- Title
- Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Reply to Mallone R [letter]
- Creators
- Moshe Phillip - Schneider Children's Medical CenterPeter Achenbach - Helmholtz Zentrum MünchenAnanta Addala - Stanford UniversityAnastasia Albanese-O’Neill - BreakthroughTadej Battelino - Ljubljana University Medical CentreKirstine J. Bell - The University of SydneyRachel E. J. Besser - University of OxfordEzio Bonifacio - Technische Universität DresdenHelen M. Colhoun - Edinburgh Cancer ResearchJennifer J. Couper - The University of AdelaideMaria E. Craig - The University of SydneyThomas Danne - BreakthroughCarine de Beaufort - Centre Hospitalier de LuxembourgKlemen Dovc - Ljubljana University Medical CentreSanjoy Dutta - BreakthroughOsagie Ebekozien - T1D ExchangeHelena Elding Larsson - Department of Clinical Sciences Malmö, Lund University CRC, Department of Pediatrics, Skåne University HospitalBrigitte I. Frohnert - University of Colorado Anschutz Medical CampusMary P. Gallagher - NYU Langone HealthCarla J. Greenbaum - Benaroya Research InstituteKurt J. Griffin - University of South DakotaWilliam Hagopian - Pacific Northwest Diabetes Research InstituteMichael J. Haller - University of FloridaEmile Hendriks - Cambridge University Hospitals NHS Foundation TrustRichard I. G. Holt - University Hospital Southampton NHS Foundation TrustHeba M. Ismail - Indiana University – Purdue University IndianapolisLaura M. Jacobsen - Florida CollegeLeslie E. Kolb - American Association of Diabetes EducatorsOlga Kordonouri - Universidade Nova de LisboaKarin Lange - Medizinische Hochschule HannoverRobert W. Lash - Endocrine SocietyÅke Lernmark - Malmö UniversityIngrid Libman - Children's Hospital of PittsburghMarkus Lundgren - Lund UniversityDavid M. Maahs - Stanford UniversityM. Loredana Marcovecchio - Cambridge University Hospitals NHS Foundation TrustChantal Mathieu - Universitair Ziekenhuis LeuvenTal Oron - Schneider Children's Medical CenterShivajirao P. Patil - East Carolina UniversityMarian J. Rewers - University of Colorado Anschutz Medical CampusStephen S. Rich - University of VirginiaDesmond A. Schatz - University of FloridaRifka Schulman-Rosenbaum - Long Island Jewish Medical CenterKimber M. Simmons - University of Colorado Anschutz Medical CampusEmily K. Sims - Indiana University – Purdue University IndianapolisJay S. Skyler - University of MiamiCate Speake - Benaroya Research InstituteAndrea K. Steck - University of Colorado Anschutz Medical CampusKsenia N. Tonyushkina - University of Massachusetts Chan Medical SchoolRiitta Veijola - Oulu University HospitalJohn M. Wentworth - Walter and Eliza Hall Institute of Medical ResearchDiane K. Wherrett - University of TorontoJamie R. Wood - Rainbow Babies & Children's HospitalAnette-Gabriele Ziegler - Helmholtz Zentrum MünchenLinda A. DiMeglio - Indiana University – Purdue University IndianapolisFaculty of Medicine
- Publication Details
- Diabetologia, Vol.68(4), pp.892-895
- Publisher
- Springer Berlin Heidelberg
- Number of pages
- 4
- Academic Unit
- Miller School of Medicine; Diabetes Research Institute (DRI)
- Language
- English
- Resource Type
- Journal article
- PMID
- 39934371
- Record Identifier
- 991032795900302976
Journal article
Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Reply to Mallone R [letter]
Diabetologia, Vol.68(4), pp.892-895
2025-04-01
PMID: 39934371
Metrics
1 Record Views